| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |